Compound Summary
Compound Name: | Velnacrine maleate |
Compound CID: | 5702293 |
Synonyms: | Velnacrine maleate 118909-22-1 9-Amino-1,2,3,4-tetrahydroacridin-1-ol maleate HYDROXYTACRINE MALEATE Mentane More... |
Iupac Name: | 9-amino-1,2,3,4-tetrahydroacridin-1-ol;(Z)-but-2-enedioic acid |
InChI: | InChI=1S/C13H14N2O.C4H4O4/c14-13-8-4-1-2-5-9(8)15-10-6-3-7-11(16)12(10)13;5-3(6)1-2-4(7)8/h1-2,4-5,11,16H,3,6-7H2,(H2,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1- |
InChIKey: | NEEKVKZFYBQFGT-BTJKTKAUSA-N |
Canonical Smiles: | C1CC(C2=C(C3=CC=CC=C3N=C2C1)N)O.C(=CC(=O)O)C(=O)O |
Isomeric Smiles: | C1CC(C2=C(C3=CC=CC=C3N=C2C1)N)O.C(=C\C(=O)O)\C(=O)O |
Molecular Weight: | 330.33 |
Molecular Formula: | C17H18N2O5 |
Molecular Weight: | 330.33 |
Molecular Formula: | C17H18N2O5 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 24 |
Complexity: | 377 |
Velnacrine maleate | Velnacrine maleate |
---|---|
Velnacrine maleate |
118909-22-1 |
9-Amino-1,2,3,4-tetrahydroacridin-1-ol maleate |
HYDROXYTACRINE MALEATE |
Mentane |
HP-029 |
HP 029 |
UNII-WR9885GALS |
Velnacrine maleate USAN |
WR9885GALS |
112964-99-5 |
UNII-4401EF6U24 |
4401EF6U24 |
P83 6029A |
9-amino-1,2,3,4-tetrahydroacridin-1-ol;(Z)-but-2-enedioic acid |
Velnacrine maleate (USAN) |
DSSTox_CID_25158 |
DSSTox_RID_80709 |
DSSTox_GSID_45158 |
SR-01000075908 |
1-hydroxy tacrine maleate |
(+-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol maleate |
Mentane (TN) |
Velnacrine maleate, (+)- |
Velnacrine maleate, (-)- |
SCHEMBL50846 |
SPECTRUM2300100 |
DTXSID7045158 |
HMS501M19 |
HMS2096I18 |
HMS3261F10 |
HMS3713I18 |
BCP08862 |
Tox21_110164 |
Tox21_500584 |
1-ACRIDINOL, 1,2,3,4-TETRAHYDRO-9-AMINO-, MALEATE, (+-)- |
CCG-39142 |
AKOS015924689 |
Tox21_110164_1 |
LP00584 |
1-Acridinol, 1,2,3,4-tetrahydro-9-amino-, (+-)-, (Z)-2-butenedioate (1:1) |
NCGC00015506-07 |
NCGC00093963-01 |
NCGC00093963-02 |
NCGC00093963-03 |
NCGC00093963-04 |
NCGC00261269-01 |
ST013732 |
AB0000342 |
P83-6029A |
EU-0100584 |
D06288 |
H 3146 |
9-Amino-1,2,3,4-tetrahydroacridine-1-ol maleate |
9-Amino-1,2,3,4-tetrahydro-acridin-1-ol, maleate |
SR-01000075908-1 |
SR-01000075908-4 |
9-Amino-1,2,3,4-tetrahydroacridin-1-ol (2Z)-but-2-enedioate |
9-amino-1,2,3,4-tetrahydroacridin-1-ol, (2Z)but-2-enedioic acid |
(+-)-9-Amino-1,2,3,4-tetrahydro-1-acridinol maleate (1:1) (salt) |
1-Acridinol, 9-amino-1,2,3,4-tetrahydro-, (+)-, (2Z)-2-butenedioate (1:1) (salt) |
1-Acridinol, 9-amino-1,2,3,4-tetrahydro-, (+)-, (Z)-2-butenedioate (1:1) (salt) |
1-Acridinol, 9-amino-1,2,3,4-tetrahydro-, (+-)-, (Z)-2-butenedioate (1:1) (salt) |
1-Acridinol, 9-amino-1,2,3,4-tetrahydro-, (-)-, (2Z)-2-butenedioate (1:1) (salt) |
1-Acridinol, 9-amino-1,2,3,4-tetrahydro-, (-)-, (Z)-2-butenedioate (1:1) (salt) |
121445-25-8 |
121445-27-0 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 4.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 4.000000000000000 | 1 | 1 |